Rennova Health Inc
Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a hospital located in Jamestown, Tennessee. The company is based in West Palm Beach, Florida.
Rennova Health Inc (RNVA) - Net Assets
Latest net assets as of December 2024: $-36.84 Million USD
Based on the latest financial reports, Rennova Health Inc (RNVA) has net assets worth $-36.84 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($20.25 Million) and total liabilities ($57.10 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-36.84 Million |
| % of Total Assets | -181.92% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 97.01 |
Rennova Health Inc - Net Assets Trend (1993–2024)
This chart illustrates how Rennova Health Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Rennova Health Inc (1993–2024)
The table below shows the annual net assets of Rennova Health Inc from 1993 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-36.84 Million | 0.00% |
| 2023-12-31 | $-36.84 Million | -26.63% |
| 2022-12-31 | $-29.09 Million | -6.57% |
| 2021-12-31 | $-27.30 Million | +44.30% |
| 2020-12-31 | $-49.02 Million | +28.82% |
| 2019-12-31 | $-68.87 Million | -75.83% |
| 2018-12-31 | $-39.17 Million | -12.62% |
| 2017-12-31 | $-34.78 Million | -133.63% |
| 2016-12-31 | $-14.89 Million | -1146.93% |
| 2015-12-31 | $-1.19 Million | -115.04% |
| 2015-03-31 | $7.94 Million | +171.32% |
| 2014-12-31 | $2.92 Million | 0.00% |
| 2013-12-31 | $2.92 Million | -48.72% |
| 2012-12-31 | $5.70 Million | -29.41% |
| 2011-12-31 | $8.08 Million | -14.12% |
| 2010-12-31 | $9.41 Million | -21.18% |
| 2009-12-31 | $11.94 Million | -60.25% |
| 2008-12-31 | $30.03 Million | -8.80% |
| 2007-12-31 | $32.93 Million | +128.41% |
| 2006-12-31 | $14.42 Million | -44.64% |
| 2005-12-31 | $26.04 Million | +95.79% |
| 2004-12-31 | $13.30 Million | -11.07% |
| 2003-12-31 | $14.96 Million | +34.45% |
| 2002-12-31 | $11.12 Million | -50.09% |
| 2001-12-31 | $22.29 Million | -22.10% |
| 2000-12-31 | $28.61 Million | +4.29% |
| 1999-12-31 | $27.43 Million | -10.94% |
| 1998-12-31 | $30.80 Million | -31.25% |
| 1997-12-31 | $44.80 Million | -5.88% |
| 1996-12-31 | $47.60 Million | +371.29% |
| 1995-12-31 | $10.10 Million | 0.00% |
| 1994-12-31 | $10.10 Million | -2.60% |
| 1993-12-31 | $10.37 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Rennova Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 169862694100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.06 Million | % |
| Other Components | $1.67 Billion | % |
| Total Equity | $-36.82 Million | 100.00% |
Rennova Health Inc Competitors by Market Cap
The table below lists competitors of Rennova Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sesa SpA
STU:1S3
|
$797.13K |
|
VISTEON (VS51.SG)
STU:VS51
|
$797.61K |
|
Ansal Properties & Infrastructure Limited
NSE:ANSALAPI
|
$797.78K |
|
I&M BANK RWANDA LTD
RSE:IMR
|
$797.89K |
|
Biodexa Pharmaceticals
NASDAQ:BDRX
|
$796.76K |
|
Coca-Cola Femsa SAB de CV
STU:CFSL
|
$796.43K |
|
Suncliff Inc
PINK:SCLF
|
$795.93K |
|
Uniserve Communications Corporation
PINK:USSHF
|
$794.05K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Rennova Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -36,823,749 to -36,823,749, a change of 0.
- Net loss of 7,729,161 reduced equity.
- Other factors increased equity by 7,729,161.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.73 Million | -20.99% |
| Other Changes | $7.73 Million | +20.99% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Rennova Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | $0.00 | $0.00 | x |
| 1994-12-31 | $10100000.00 | $0.00 | x |
| 1995-12-31 | $3366666.67 | $0.00 | x |
| 1996-12-31 | $1286486.49 | $0.00 | x |
| 1997-12-31 | $1148717.95 | $0.00 | x |
| 1998-12-31 | $789743.59 | $0.00 | x |
| 1999-12-31 | $596326.09 | $0.00 | x |
| 2000-12-31 | $621934.78 | $0.00 | x |
| 2001-12-31 | $428576.92 | $0.00 | x |
| 2002-12-31 | $188525.42 | $0.00 | x |
| 2003-12-31 | $110777.78 | $0.00 | x |
| 2004-12-31 | $68205.13 | $0.00 | x |
| 2005-12-31 | $83729.90 | $0.00 | x |
| 2006-12-31 | $45623.42 | $0.00 | x |
| 2007-12-31 | $51747.44 | $0.00 | x |
| 2008-12-31 | $42994.17 | $0.00 | x |
| 2009-12-31 | $15941.51 | $0.00 | x |
| 2010-12-31 | $12534.14 | $0.00 | x |
| 2011-12-31 | $10763.72 | $0.00 | x |
| 2012-12-31 | $6914.86 | $0.00 | x |
| 2013-12-31 | $3349.25 | $0.00 | x |
| 2014-12-31 | $1257.52 | $0.00 | x |
| 2015-03-31 | $3411.87 | $0.00 | x |
| 2015-12-31 | $-43.24 | $0.00 | x |
| 2016-12-31 | $-206.36 | $0.00 | x |
| 2017-12-31 | $-11592722.33 | $0.00 | x |
| 2018-12-31 | $-3046.66 | $0.00 | x |
| 2019-12-31 | $-68716.69 | $0.00 | x |
| 2020-12-31 | $-16339.25 | $0.00 | x |
| 2021-12-31 | $-49.79 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
| 2024-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Rennova Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -41.36%
- • Asset Turnover: 0.92x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-37.01%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | -14.48% | -3.95% | 1.38x | 2.65x | $-2.54 Million |
| 1994 | 7.92% | 1.79% | 1.32x | 3.34x | $-210.00K |
| 1995 | 7.92% | 1.79% | 1.32x | 3.34x | $-210.00K |
| 1996 | 11.76% | 9.03% | 0.97x | 1.34x | $840.00K |
| 1997 | -12.28% | -13.25% | 0.75x | 1.23x | $-9.98 Million |
| 1998 | -49.03% | -52.07% | 0.73x | 1.29x | $-18.18 Million |
| 1999 | -45.83% | -47.55% | 0.74x | 1.30x | $-15.31 Million |
| 2000 | 2.44% | 1.83% | 0.90x | 1.48x | $-2.16 Million |
| 2001 | -39.17% | -40.41% | 0.74x | 1.31x | $-10.96 Million |
| 2002 | -113.50% | -89.54% | 0.82x | 1.55x | $-13.74 Million |
| 2003 | -84.27% | -76.25% | 0.73x | 1.52x | $-14.10 Million |
| 2004 | -115.51% | -103.19% | 0.74x | 1.51x | $-16.69 Million |
| 2005 | -34.10% | -40.81% | 0.69x | 1.21x | $-11.48 Million |
| 2006 | -91.65% | -59.35% | 0.53x | 2.89x | $-14.65 Million |
| 2007 | 54.98% | 54.99% | 0.82x | 1.22x | $14.81 Million |
| 2008 | -26.31% | -60.46% | 0.38x | 1.14x | $-10.91 Million |
| 2009 | -154.72% | -148.97% | 0.76x | 1.37x | $-19.66 Million |
| 2010 | -38.64% | -22725.00% | 0.00x | 1.19x | $-4.58 Million |
| 2011 | -53.95% | -4359.00% | 0.01x | 1.07x | $-5.17 Million |
| 2012 | -68.86% | -982.00% | 0.06x | 1.22x | $-4.50 Million |
| 2013 | -122.43% | -544.22% | 0.15x | 1.48x | $-3.87 Million |
| 2014 | -176.55% | -1036.95% | 0.12x | 1.48x | $-5.46 Million |
| 2015 | -65.07% | -1036.95% | 0.05x | 1.17x | $-5.96 Million |
| 2015 | 0.00% | -195.52% | 0.63x | 0.00x | $-35.84 Million |
| 2016 | 0.00% | -976.92% | 0.51x | 0.00x | $-31.13 Million |
| 2017 | 0.00% | -1787.37% | 0.49x | 0.00x | $-51.72 Million |
| 2018 | 0.00% | -96.38% | 1.02x | 0.00x | $-10.11 Million |
| 2019 | 0.00% | -300.15% | 1.09x | 0.00x | $-41.15 Million |
| 2020 | 0.00% | -254.71% | 0.59x | 0.00x | $-13.44 Million |
| 2021 | 0.00% | 173.86% | 0.16x | 0.00x | $8.34 Million |
| 2022 | 0.00% | -25.26% | 0.63x | 0.00x | $-383.60K |
| 2023 | 0.00% | -41.36% | 0.92x | 0.00x | $-4.05 Million |
| 2024 | 0.00% | -41.36% | 0.92x | 0.00x | $-4.05 Million |
Industry Comparison
This section compares Rennova Health Inc's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Rennova Health Inc (RNVA) | $-36.84 Million | -14.48% | N/A | $797.09K |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |